comparemela.com

Latest Breaking News On - Nicolas derval - Page 1 : comparemela.com

EHRA 2023 Hot Takes

These were the topics that sizzled at the European Heart Rhythm Association (EHRA) congress this week in Barcelona, Spain.

Switzerland
Geneva
Genè
France
Sweden
Stockholm
Spain
Barcelona
Comunidad-autonoma-de-cataluna
Canada
United-states
Canadian

Novel ablation strategy improved arrhythmia recurrence vs. pulmonary vein isolation only

In a small, single-center trial, the novel Marshall-Plan ablation strategy improved 10-month arrhythmia recurrence compared with pulmonary vein isolation alone for persistent atrial fibrillation, a speaker reported.“After 10 months of follow up, the success rate in the Marshall-Plan group was significantly better (87%) compared to the PVI only group (70%),” Nicolas Derval, MD, head of

France
Barcelona
Comunidad-autonoma-de-cataluna
Spain
Nicolas-derval
Erik-swain
Byscott-buzby
Biosense-webster
European-heart-rhythm-association
University-hospital-of-bordeaux
Breaking-science
Annual-congress

Marshall-Plan ablation strategy may help control arrhythmias in patients with persistent AF

France: In patients with persistent atrial fibrillation, an innovative three-step ablation approach, including ethanol infusion of the vein of Marshal, was shown to improve freedom from arrhythmias.

France
Nicolas-derval
University-hospital-of-bordeaux
European-society-of-cardiology
European-society
Marshall-plan
University-hospital
Arrhythmias
Atrial-fibrillation
Pulmonary-vein-isolation
Echocardiography

New Ablation Strategy Enhances Arrhythmia-Free Outcome in Atrial Fibrillation Patients

New Ablation Strategy Enhances Arrhythmia-Free Outcome in Atrial Fibrillation Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

France
Nicolas-derval
University-hospital-of-bordeaux
European-society-of-cardiology
European-society
University-hospital

vimarsana © 2020. All Rights Reserved.